A detailed history of Deutsche Bank Ag\ transactions in Humacyte, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 101,086 shares of HUMA stock, worth $119,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
101,086
Previous 88,828 13.8%
Holding current value
$119,281
Previous $185,000 5.41%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$1.41 - $2.73 $17,283 - $33,464
12,258 Added 13.8%
101,086 $175,000
Q2 2025

Aug 12, 2025

BUY
$1.15 - $2.77 $21,931 - $52,826
19,071 Added 27.34%
88,828 $185,000
Q1 2025

May 09, 2025

SELL
$1.71 - $5.18 $14,906 - $45,154
-8,717 Reduced 11.11%
69,757 $119,000
Q4 2024

Jun 30, 2025

BUY
$3.46 - $5.81 $30,160 - $50,645
8,717 Added 12.5%
78,474 $396,000
Q4 2024

Feb 14, 2025

BUY
$3.46 - $5.81 $91,409 - $153,494
26,419 Added 50.75%
78,474 $396,000
Q3 2024

Jun 26, 2025

SELL
$5.11 - $9.46 $90,457 - $167,460
-17,702 Reduced 25.38%
52,055 $283,000
Q3 2024

Nov 13, 2024

BUY
$5.11 - $9.46 $160,264 - $296,693
31,363 Added 151.57%
52,055 $283,000
Q2 2024

Jun 12, 2025

SELL
$2.87 - $9.1 $140,816 - $446,491
-49,065 Reduced 70.34%
20,692 $99,000
Q2 2024

Aug 14, 2024

SELL
$2.87 - $9.1 $21,955 - $69,615
-7,650 Reduced 26.99%
20,692 $99,000
Q1 2024

Jun 02, 2025

SELL
$2.57 - $4.84 $106,436 - $200,448
-41,415 Reduced 59.37%
28,342 $88,000
Q1 2024

May 15, 2024

SELL
$2.57 - $4.84 $2,898 - $5,459
-1,128 Reduced 3.83%
28,342 $88,000
Q4 2023

Feb 14, 2024

SELL
$1.99 - $3.12 $3,697 - $5,796
-1,858 Reduced 5.93%
29,470 $83,000
Q3 2023

Nov 09, 2023

SELL
$2.75 - $4.48 $800 - $1,303
-291 Reduced 0.92%
31,328 $91,000
Q2 2023

Aug 14, 2023

SELL
$2.86 - $4.97 $26,088 - $45,336
-9,122 Reduced 22.39%
31,619 $90,000
Q1 2023

May 15, 2023

BUY
$2.11 - $3.25 $32,506 - $50,069
15,406 Added 60.81%
40,741 $125,000
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.62 $36,707 - $65,782
18,172 Added 253.69%
25,335 $53,000
Q3 2022

Nov 14, 2022

SELL
$1.22 - $5.14 $1,439 - $6,065
-1,180 Reduced 14.14%
7,163 $23,000
Q2 2022

Aug 11, 2022

BUY
$3.21 - $7.86 $26,781 - $65,575
8,343 New
8,343 $27,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $122M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.